Palisade Bio, Inc. issued common stock purchase options, restricted stock units, and performance restricted stock units to certain officers and members of senior management, subject to shareholder approval. They also appointed Robert McRae as Chief Operating Officer and increased the base salary and target bonus of J.D. Finley. A press release was issued regarding these appointments.